Direct Lobbying Transparency
| Overall Assessment | Comment | Score |
|---|---|---|
| Comprehensive | Takeda Pharmaceutical provides a highly detailed picture of its climate-policy lobbying. It names multiple concrete policy files it has worked on, including the Japanese Government’s “2050 Net Zero Emissions Target,” the “introduction of carbon pricing,” the creation of “a renewable energy Power Purchase Agreement system,” and tariff reforms linked to Japan’s NDC, allowing readers to see exactly which pieces of legislation or regulation are being influenced. The company also explains how it engages: as part of the Japan Climate Leaders Partnership it has “met with the Japan Minister of Environment, Minister for Administrative Reform and Deputy Minister of Economy, Trade and Industry,” “handed a written opinion directly to the Prime Minister of Japan,” and sat on the “advisory panel for the National Council of the Agency for Natural Resources and Energy,” supplementing those meetings with written policy recommendations and public position papers. Finally, Takeda is explicit about the outcomes it pursues, stating that it seeks to “introduce carbon pricing in order to overcome [the] climate crisis,” to “realize a renewable energy Power Purchase Agreement system… in Japan,” and to expand renewable energy so as to strengthen “corporate competitiveness and a sustainable society,” as well as to secure an “ideal basic tariff for power generation consignment charges.” Together these disclosures demonstrate comprehensive transparency on the policies addressed, the channels used, and the specific policy changes the company is advocating. | 4 |